NeuroSense Therapeutics (NRSN) Short-term Investments (2021 - 2025)

NeuroSense Therapeutics has reported Short-term Investments for 5 years, with the latest figure at $47000.0 in Q4 2025.

• Quarterly Short-term Investments rose 34.29% year-over-year to $47000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $47000.0 (up 34.29% YoY) and the FY2025 annual result came in at $47000.0, up 34.29% from the prior year.
• Short-term Investments rose to $47000.0 in Q4 2025 per NRSN's latest filing, from $43000.0 in the prior quarter.
• Over five years, Short-term Investments peaked at $64000.0 in Q1 2022 and troughed at $23000.0 in Q2 2022.
• A 5-year average of $38545.5 and a median of $39000.0 in 2021 frame the typical range for Short-term Investments.
• The sharpest annual moves came in 2023 and 2025: Short-term Investments plunged 39.06% in 2023, then surged 34.29% in 2025.
• Over 5 years, Short-term Investments stood at $39000.0 in 2021, then slipped by 7.69% to $36000.0 in 2022, then rose by 11.11% to $40000.0 in 2023, then retreated by 12.5% to $35000.0 in 2024, then soared by 34.29% to $47000.0 in 2025.
• According to Business Quant data, Short-term Investments over the past three periods registered $47000.0, $43000.0, and $35000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.